You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金城醫藥(300233.SZ):子公司3個藥品取得藥品再註冊批件
格隆匯 06-12 16:55

格隆匯6月12日丨金城醫藥(300233.SZ)宣佈,公司於2020年6月12日收到全資子公司金城泰爾通知,其獲得了北京市藥品監督管理局下發的藥品再註冊批件。經審查,金城泰爾申報的普羅雌烯乳膏、普羅雌烯陰道用軟膠囊、氯喹那多-普羅雌烯陰道片符合《藥品註冊管理辦法》的有關規定,同意再註冊。

普羅雌烯乳膏主要適用於外陰、前庭部及陰道環部的萎縮性病變;普羅雌烯陰道用軟膠囊主要適用於因雌激素不足引起的陰道萎縮;宮頸、陰道和外陰的粘膜部分因分娩、局部手術或物理療法(如激光、冷凍或燒灼等)等引起損傷的遷延不愈,結痂延遲;氯喹那多-普羅雌烯陰道片主要適用於除淋球菌外,各種陰道感染引起的白帶增多。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account